Noninvasive technology assessment: how should treatment of ovarian carcinoma be assessed?
Brenner
D E
DE
Schoeppel
S
S
Roberts
J A
JA
D015295:Antigens, Tumor-Associated, Carbohydrate / Q000097:blood; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D010051:Ovarian Neoplasms / Q000188:drug therapy*; D014057:Tomography, X-Ray Computed
D015295:Antigens, Tumor-Associated, Carbohydrate